ARTICLE | Company News
PeriCor, Schering-Plough deal
July 23, 2007 7:00 AM UTC
SGP will receive an exclusive worldwide license to develop and commercialize PeriCor's IV acadesine. The adenosine modulator is in Phase III testing to prevent ischemia/reperfusion injury. Financial t...